1.
Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study.
Gao Liqin, Song Yanping, Sun Xiaodong, Zhang Junjun, Liu Yuling, Chen Youxin et al.
Acta OphthalmolNov 20232 citationsRandomized Controlled Trial
Conbercept injections effectively improved vision and reduced retinal fluid in patients with myopic CNV, offering a safe and effective treatment option.